These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2226108)
1. Insulin use in NIDDM. Rationale based on pathophysiology of disease. Turner RC; Holman RR Diabetes Care; 1990 Sep; 13(9):1011-20. PubMed ID: 2226108 [TBL] [Abstract][Full Text] [Related]
2. Insulin therapy in type II diabetes. Holman RR; Turner RC Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S179-84. PubMed ID: 8529512 [TBL] [Abstract][Full Text] [Related]
3. Treatment of NIDDM with insulin agonists or substitutes. Galloway JA Diabetes Care; 1990 Dec; 13(12):1209-39. PubMed ID: 1980453 [TBL] [Abstract][Full Text] [Related]
4. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin. Riccio A; Avogaro A; Valerio A; Zappella A; Tiengo A; Del Prato S Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521 [TBL] [Abstract][Full Text] [Related]
11. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
12. Type II diabetes mellitus. Edelman SV Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190 [TBL] [Abstract][Full Text] [Related]
13. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Porte D Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568 [TBL] [Abstract][Full Text] [Related]
15. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749 [TBL] [Abstract][Full Text] [Related]
16. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Ivy JL Sports Med; 1997 Nov; 24(5):321-36. PubMed ID: 9368278 [TBL] [Abstract][Full Text] [Related]
17. Effect of conventional and intensified insulin therapy on free-insulin profiles and glycemic control in NIDDM. Lindström TH; Arnqvist HJ; von Schenck HH Diabetes Care; 1992 Jan; 15(1):27-34. PubMed ID: 1737539 [TBL] [Abstract][Full Text] [Related]
18. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585 [TBL] [Abstract][Full Text] [Related]
19. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. McMahon M; Marsh HM; Rizza RA Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963 [TBL] [Abstract][Full Text] [Related]